Evidence map›Paper›PMID 34211028›Full record

Observational studyScientific reports2021

Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes.

Sarega Gurudas, Manjula Nugawela, A Toby Prevost, Thirunavukkarasu Sathish, Rohini Mathur, J M Rafferty, Kevin Blighe, Ramachandran Rajalakshmi, Anjana R Mohan, Jebarani Saravanan and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Sarega Gurudas *Institute of Ophthalmology, University College London, London, UK.
Manjula Nugawela *Institute of Ophthalmology, University College London, London, UK.
A Toby PrevostNightingale-Saunders Clinical Trials and Epidemiology Unit, King's College London, London, UK.
Thirunavukkarasu SathishDepartment of Primary Care and Public Health, Imperial College London, London, UK.
Rohini MathurInstitute of Applied Data Science, Queen Mary's University London, London, UK.
J M RaffertySwansea University, Wales, UK.
Kevin BligheInstitute of Ophthalmology, University College London, London, UK.
Ramachandran RajalakshmiMadras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.
Anjana R MohanMadras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.
Jebarani SaravananMadras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.
Azeem MajeedSchool of Public, Health Imperial College London, London, UK.
Viswanthan MohanMadras Diabetes Research Foundation, Dr Mohan's Diabetes Specialities Centre, Chennai, India.
David R OwensSwansea University, Wales, UK.
John RobsonInstitute of Applied Data Science, Queen Mary's University London, London, UK.
Sobha SivaprasadNIHR Moorfields Biomedical Research Centre, University College London, City Road, London, 162EC1V 2PD, UK. s.sivaprasad@ucl.ac.uk.
ORNATE India Study Group
University College London · GBDr. Mohan's Diabetes Specialities Centre · INImperial College London · GBQueen Mary University of London · GBSwansea University · GBKing's College London · GBMadras Diabetes Research Foundation · IN

Funding

Department of HealthMedical Research Council MR/P027881/1Wellcome Trust 201375/Z/16/Z
6 · The paper itself

Abstract

Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m

Indexed as

AdultAgedDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateHumansIncidenceMaleMiddle AgedPrognosisRenal Insufficiency, ChronicRisk Factors

Identifiers

PMID34211028
PMCPMC8249456
OpenAlexW3174072282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.